The matrix metalloproteinases and their inhibitors in the treatment of pancreatic cancer.
about
Proteomic analysis identifies MMP-9, DJ-1 and A1BG as overexpressed proteins in pancreatic juice from pancreatic ductal adenocarcinoma patientsInhibitory effect of acetylsalicylic acid on matrix metalloproteinase - 2 activity in human endothelial cells exposed to high glucoseA phase II trial of marimastat in advanced pancreatic cancerSerum biomarker panels for the detection of pancreatic cancerChemopreventive effect of Cousinia shulabadensis Attar & Ghahraman ethanol extract.GSK3beta and beta-catenin modulate radiation cytotoxicity in pancreatic cancer.Novel non-operative treatment and treatment strategies in pancreatic cancer.A case of tumor betrayal: biphasic effects of TIMP-1 on Burkitt's lymphomaMolecular-targeted agents in pancreatic cancer.Keratinocyte growth factor induces matrix metalloproteinase-9 expression and correlates with venous invasion in pancreatic cancerCell phenotypic variation in normal and damaged tendons.Two matrix metalloproteinase inhibitors from scrophularia striata boiss.Systemic delivery of microencapsulated 3-bromopyruvate for the therapy of pancreatic cancer.Targeting stroma in pancreatic cancer: Promises and failures of targeted therapies.Bee venom, immunostimulant or immunosuppressor? Insight into the effect on matrix metalloproteinases and interferons.Chemoprevention by pyrimethamine.Targeting the cytotoxicity of fusogenic membrane glycoproteins in gliomas through protease-substrate interaction.Chondrocyte phenotype and ectopic ossification in collagenase-induced tendon degeneration.X-ray irradiation and Rho-kinase inhibitor additively induce invasiveness of the cells of the pancreatic cancer line, MIAPaCa-2, which exhibits mesenchymal and amoeboid motility.Do anti-stroma therapies improve extrinsic resistance to increase the efficacy of gemcitabine in pancreatic cancer?Treatment with BB-94, a broad spectrum inhibitor of zinc-dependent metalloproteinases, causes deviation of the cytokine profile towards type-2 in experimental pulmonary tuberculosis in Balb/c mice.
P2860
Q21260399-BE27FD4A-480A-4622-AFA7-7639526F4553Q28194018-48BD8CE2-D6DB-4476-9BD8-09FB968259CEQ28366568-D6FD3EED-87F1-4FC8-923A-08A737C073CAQ30499531-DDC21C4F-754B-47DE-B69E-1C6249FCCCD6Q33630024-A82CEE7D-73DF-426D-98A2-58C2B77FA74EQ33829414-8776E7B7-C99E-4CBE-8B8F-893FF0806EA0Q34074879-51BB1F9B-0B44-418F-A8F6-98DC3940C057Q34210085-B347B751-E025-4ED6-834D-C8BD03084E06Q35641998-908BB1CB-D1E6-4456-929E-85A5070687ADQ36645390-B1CC422F-2E81-422A-B9F9-2D71E5EC225BQ36909464-2F2DDE54-89F5-4FAE-B409-AAC987F33ADEQ37700696-10D4C3AD-1894-4F2E-9D2F-B3CB91C93893Q38946885-555FE1E9-8AC2-4447-8ADB-24A7C8429981Q39085104-95D22CC6-499C-4D1D-B91F-27BCF8B395E4Q40325286-37A5E7CA-E604-42A5-A9F1-CF660D2F108AQ40382683-CA04D581-EF72-4D2F-9974-6D0FBEAB3772Q40653941-6271772E-43CA-4878-896F-69A7F3F46C2BQ42143937-6AAC2EE7-022C-4B6A-AEBE-9BF543F585A5Q42482269-C2B2BDB0-AF06-41E3-AA1F-CECEE8F5DBEEQ48219198-DDEE9457-7146-419E-B964-29094D4F8A70Q52925325-0824F514-69FD-4794-A547-A10DAD637310
P2860
The matrix metalloproteinases and their inhibitors in the treatment of pancreatic cancer.
description
1999 nî lūn-bûn
@nan
1999 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հունիսին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
The matrix metalloproteinases and their inhibitors in the treatment of pancreatic cancer.
@ast
The matrix metalloproteinases and their inhibitors in the treatment of pancreatic cancer.
@en
type
label
The matrix metalloproteinases and their inhibitors in the treatment of pancreatic cancer.
@ast
The matrix metalloproteinases and their inhibitors in the treatment of pancreatic cancer.
@en
prefLabel
The matrix metalloproteinases and their inhibitors in the treatment of pancreatic cancer.
@ast
The matrix metalloproteinases and their inhibitors in the treatment of pancreatic cancer.
@en
P2093
P2860
P1476
The matrix metalloproteinases and their inhibitors in the treatment of pancreatic cancer
@en
P2093
P2860
P304
P356
10.1111/J.1749-6632.1999.TB09533.X
P407
P577
1999-06-01T00:00:00Z